Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001168197-13-000007
Filing Date
2013-03-27
Accepted
2013-03-27 16:10:06
Documents
13
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10-K lpdx-20121231x10k.htm 10-K 2567495
2 EXHIBIT exhibit1032amendedandresta.htm EX-10.32 37083
3 EXHIBIT exhibit1033amendedandresta.htm EX-10.33 30688
4 EXHIBIT exhibit1034amendedandresta.htm EX-10.34 31529
5 EXHIBIT exhibit1035amendedandresta.htm EX-10.35 30359
6 EXHIBIT exhibit1036amendedandresta.htm EX-10.36 30275
7 EXHIBIT exhibit10382012corporatego.htm EX-10.38 13687
8 EXHIBIT exhibit231consentofernstyo.htm EX-23.1 2149
9 EXHIBIT exhibit311certificationofp.htm EX-31.1 9864
10 EXHIBIT exhibit312certificationofp.htm EX-31.2 10211
11 EXHIBIT exhibit32certificationofpr.htm EX-32 10620
12 image1.jpg GRAPHIC 50889
13 image2.jpg GRAPHIC 46827
  Complete submission text file 0001168197-13-000007.txt   2909796
Mailing Address 2500 SUMNER BOULEVARD RALEIGH NC 27616
Business Address 2500 SUMNER BOULEVARD RALEIGH NC 27616 9192121999
LIPOSCIENCE INC (Filer) CIK: 0001168197 (see all company filings)

EIN.: 561879288 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35792 | Film No.: 13720112
SIC: 2835 In Vitro & In Vivo Diagnostic Substances